Literature DB >> 26428642

Once-a-day Tadalafil administration improves the spermogram parameters in fertile patients.

Antonio Corvasce1, Giuseppe Albino, Teresa Leonetti, Agnese Filomena Buonomo, Ettore Cirillo Marucco.   

Abstract

OBJECTIVES: We explored the safety of Tadalafil once-daily treatment for 12 week and its effects on semen quality in a clinical subpopulation of men with psychogenic erectile dysfunction (ED). PATIENTS AND METHODS: Twenty-seven men, between 19 and 35 years, unaware of their fertility status, suffering from psychogenic ED were enrolled. The examination of the seminal fluid was performed twice before administration of Tadalafil and twice after three months of continuous daily administration of Tadalafil 5 mg. The volume of the seminal fluid, the concentration of sperm, the concentration of sperm with type "a+b" motility, the concentration of sperm with type "a" motility, the concentration of normal sperm were taken into consideration. The results before treatment with Tadalafil (T0) and after 3 months of treatment (T3m) were compared.
RESULTS: The administration of once-daily Tadalafil 5mg, brings to an average increase of the total number of sperm cells, both total and fast motility (type a) and the percentage of nemasperms, and to an average increase of semen volume of only 0.41 ml. These quantitative and qualitative improvements of the seminal fluid resulted statistically significant as regard motility, nemasperm percentage and seminal fluid volume. No unespected safety findings were observed.
CONCLUSIONS: Tadalafil administration improves the quality of sperm cells and seminal fluid: in particular motility, percentage of nemasperms and volume of seminal fluid. We emphasize the safety of the once-daily treatment with tadalafil 5mg and the positive effects on spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26428642     DOI: 10.4081/aiua.2015.3.210

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  6 in total

Review 1.  FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction.

Authors:  Elizabeth R Rayburn; Liang Gao; Jiayi Ding; Hongxia Ding; Jun Shao; Haibo Li
Journal:  J Assist Reprod Genet       Date:  2017-10-24       Impact factor: 3.412

2.  Effect of phosphodiesterase type 5 inhibitors on sperm motility and acrosome reaction: An in vitro study.

Authors:  Seung Hun Song; Dong Hyuk Shin; Young Sun Her; Mi Hee Oh; Jung Won Baek; Suye Sung; Jin Hee Eum; Yohan Heo; Dong Suk Kim
Journal:  Investig Clin Urol       Date:  2021-05

3.  Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study.

Authors:  Sandro La Vignera; Rosita A Condorelli; Laura M Mongioi; Aldo E Calogero
Journal:  Int J Endocrinol       Date:  2017-03-30       Impact factor: 3.257

4.  Effect of phosphodiesterase-5 inhibitors (PDE5is) on the treatment of male infertility: A protocol for systematic review and meta-analysis.

Authors:  Liang Dong; Xiaojin Zhang; Xuhong Yan; Yifeng Shen; Xujun Yu; Yulin Li
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

Review 5.  Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review).

Authors:  Hao Su; Chengquan Ma; Hongjun Li
Journal:  Exp Ther Med       Date:  2021-02-03       Impact factor: 2.447

Review 6.  Male Sexual Dysfunctions in the Infertile Couple-Recommendations From the European Society of Sexual Medicine (ESSM).

Authors:  Paolo Capogrosso; Christian Fuglesang S Jensen; Giulia Rastrelli; Josep Torremade; Giorgio I Russo; Amr Abdel Raheem; Anders Frey; Mikkel Fode; Mario Maggi; Yacov Reisman; Carlo Bettocchi; Giovanni Corona
Journal:  Sex Med       Date:  2021-06-02       Impact factor: 2.491

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.